Conclusions: Non-inferiority with respect to tfn was demonstrated between DA 200 Q2W compared with EA 40,000 QW in a large, randomized phase 3 study. Similar efficacy was seen for Hb, PRO and safety ...

This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...

Does one person provide it all? Defining the social support of women with cancer Pts with adverse events - n (%) 46 (79) 49 (88) 95 (83) Pts with serious adverse events - n (%) 18 (31) 21 (38) 39 (34) ...